|
|
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings
|
|
|
|
HC Wainwright & Co. Downgrades Arcellx to Neutral, Maintains Price Target to $115
|
|
|
|
Baird Downgrades Arcellx to Neutral, Raises Price Target to $115
|
|
|
|
12 Health Care Stocks Moving In Monday's Intraday Session
|
|
|
|
Needham Downgrades Arcellx to Hold
|
|
|
|
ImmunityBio Posts Upbeat Q4 Earnings, Joins Arcellx, Vanda Pharmaceuticals And Other Big Stocks Moving Higher On Monday
|
|
|
|
US Stocks Mixed; Domino's Pizza Shares Gain After Q4 Earnings
|
|
|
|
Wells Fargo Downgrades Arcellx to Equal-Weight, Announces $115 Price Target
|
|
|
|
Arcellx shares are trading higher after the company announced it will be acquired by Gilead Sciences.
|
|
|
|
Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug
|
|